📰 Director Jeryl News
Director Jeryl News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Director Jeryl. Real-time updates on events, politics, business and more.
September 17, 2023
SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) saw a significant drop in short interest in August. As of August 31st, there was short interest totalling 742,500 shares, a drop of 22.3% from the August 15th total of 955,900 shares. Based on an average daily trading volume, of 375,000 shares, the days-to-cover ratio is presently 2.0 […]
September 11, 2023
Royce & Associates LP grew its position in shares of SI-BONE, Inc. (NASDAQ:SIBN – Free Report) by 37.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 132,000 shares of the company’s stock after acquiring an additional 36,000 shares […]
August 25, 2023
Cantor Fitzgerald restated their overweight rating on shares of SI-BONE (NASDAQ:SIBN – Free Report) in a research report released on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $30.00 price target on the stock. Several other equities analysts have also recently issued reports on the company. Needham & Company LLC reissued a buy rating and […]
July 5, 2023
SI-BONE, Inc. (NASDAQ:SIBN – Free Report) has received a consensus rating of “Buy” from the seven analysts that are covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $26.25. A […]
August 1, 2022
Arizona State Retirement System grew its holdings in shares of NovoCure Limited (NASDAQ:NVCR – Get Rating) by 2.4% in the 1st quarter, Holdings Channel.com reports. The firm owned 26,009 shares of the medical equipment provider’s stock after purchasing an additional 611 shares during the quarter. Arizona State Retirement System’s holdings in NovoCure were worth $2,155,000 […]
July 18, 2022
Sumitomo Mitsui Trust Holdings Inc. purchased a new position in NovoCure Limited (NASDAQ:NVCR – Get Rating) in the first quarter, HoldingsChannel.com reports. The firm purchased 257,844 shares of the medical equipment provider’s stock, valued at approximately $21,362,000. A number of other hedge funds and other institutional investors have also bought and sold shares of the […]